195990 — ABPro Bio Co Income Statement

0.000.00%

Last trade - 00:00

IndustrialsHighly SpeculativeMicro CapSucker Stock

Annual income statement for ABPro Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	32,914	22,112	25,375	31,663	31,923
Cost of Revenue
Gross Profit	3,928	1,619	1,269	616	3,511
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	37,875	22,612	35,270	68,617	79,014
Operating Profit	-4,961	-500	-9,894	-36,954	-47,091
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-9,675	-8,145	-25,658	-16,056	-49,336
Provision for Income Taxes
Net Income After Taxes	-9,740	-8,145	-25,742	-15,629	-48,920
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-10,030	-8,145	-25,742	-15,629	-48,920
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-10,030	-8,145	-25,742	-15,629	-48,920
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-387	-611	-898	-208	-853
Dividends per Share